Christopher Edward Jensen

6PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)RehabilitationMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 27, 2026
Treatment Initiation Among Black and White Older Adults With Multiple Myeloma: A SEER-Medicare Analysis.

Matthew R LeBlanc, Xi Zhou, Christopher D Baggett

|Aug 11, 2025
Comparison of standardized uptake value and standardized uptake lean body mass metrics in 18F-fluorodeoxyglucose positron emission tomography for assessing transformation in chronic lymphocytic leukemia and follicular lymphoma.

Jorge D Oldan, Christopher E Jensen, Deborah M Stephens

|Dec 19, 2024
Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.

Nilanjan Ghosh, Toby A Eyre, Jennifer R Brown

|Feb 06, 2024
Functional Status Associations With Treatment Receipt and Outcomes Among Older Adults Newly Diagnosed With Multiple Myeloma.

Christopher Edward Jensen, Tzy-Mey Kuo, Matthew R LeBlanc

|Nov 29, 2022
Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia.

Christopher E Jensen, Nathan D Montgomery, Jonathan Galeotti

|May 05, 2022
Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life.

Christopher E Jensen, Sanah N Vohra, Kirsten A Nyrop

Pageof 1

Frequent Collaborators

2 joint publications

Katherine E Reeder-Hayes

2 joint publications

Tzy-Mey Kuo

2 joint publications

Jennifer L Lund

2 joint publications

Matthew R LeBlanc